期刊文献+

Nicotine suppresses lipopolysaccharide-induced release of interleukin-6 in mixed glia and microglia-enriched cultures

Nicotine suppresses lipopolysaccharide-induced release of interleukin-6 in mixed glia and microglia-enriched cultures
下载PDF
导出
摘要 Inflammation plays an important role in the pathogenesis of Parkinson's disease (PD) through the over-activation of microglia. Epidemiological studies show that smoking is associated with a lower incidence of PD. This study hypothesized that the neuroprotective effect of nicotine is mediated by modulating the activation of microglia via cytokine release. This study found that nicotine pretreatment suppressed the lipopolysaccharide-induced inflammatory reaction in the nervous system, especially microglia activation and interleukin-6 production. The inhibitory effects of 100 pmol/L nicotine were stronger compared with 1 and 10 iJmol/L nicotine. These findings indicate that nicotine significantly decreases the production of proinflammatory interleukin-6 in mixed glia or microglia-enriched cultures, and plays an inhibitory effect on the lipopolysaccharide-induced inflammatory reaction. Inflammation plays an important role in the pathogenesis of Parkinson's disease (PD) through the over-activation of microglia. Epidemiological studies show that smoking is associated with a lower incidence of PD. This study hypothesized that the neuroprotective effect of nicotine is mediated by modulating the activation of microglia via cytokine release. This study found that nicotine pretreatment suppressed the lipopolysaccharide-induced inflammatory reaction in the nervous system, especially microglia activation and interleukin-6 production. The inhibitory effects of 100 pmol/L nicotine were stronger compared with 1 and 10 iJmol/L nicotine. These findings indicate that nicotine significantly decreases the production of proinflammatory interleukin-6 in mixed glia or microglia-enriched cultures, and plays an inhibitory effect on the lipopolysaccharide-induced inflammatory reaction.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第5期325-329,共5页 中国神经再生研究(英文版)
基金 Supported by the National Natural Science Foundation of China, No. 30671103
关键词 NICOTINE GLIA cytokine LIPOPOLYSACCHARIDES Parkinson's disease nicotine glia cytokine lipopolysaccharides Parkinson's disease
  • 相关文献

参考文献1

二级参考文献8

  • 1Gao Z G,Cui W Y,Zhang H T,et al.Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice[J].Pharmacol Res,1998,38(2):101-106.
  • 2Maggio R,Riva M,Vaglini F,et al.Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors[J].J Neurochem,1998,71(6):2439-2446.
  • 3Abin-Carriquiry J A,Costa G,Urbanavicius J,et al.In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives:implications for Parkinsons Disease[J].Eur J Pharmacol,2008,589(1-3):80-84.
  • 4Ohsawa K,Imai Y,Sasaki Y,et al.Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity[J].J Neurochem,2004,88(4):844-856.
  • 5Jeohn G H,Cooper C L,Wilson B,et al.p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures[J].Ann N Y Acad Sci,2002,962:332-346.
  • 6Bezzi P,Volterra A.A neuron-glia signalling network in the active brain[J].Curr Opin Neurobiol,2001,11(3):387-394.
  • 7Lemay S,Chouinard S,Blanchet P,et al.Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinsons disease[J].Prog Neuropsychopharmacol Biol Psychiatry,2004,28(1):31-39.
  • 8Quik M,Bordia T,OLeary K.Nicotinic receptors as CNS targets for Parkinson's disease[J].Biochem Pharmacol,2007,74(8):1224-1234.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部